Haoxi Health Technology Limited cash flow to debt ratio of -168.34% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Haoxi Health Technology Limited's free cash flow has decreased 318.22% from $-802.94K last year to $-3.36M, signaling decreasing performance

Haoxi Health Technology Limited's debt to equity ratio is 0.10, which means that the company's assets are healthy financed, signaling financial stability.

Haoxi Health Technology Limited's debt has decreased relative to shareholder equity from 0.11 last year to 0.10 today, signaling strengthened financials

Haoxi Health Technology Limited has a net cash position, so leverage is healthy.

Haoxi Health Technology Limited earns at least as much interest as it pays. Interest obligations are fully covered.

Haoxi Health Technology Limited's profit margin has decreased (343.98%) in the last year from 2.66% to -6.50%, signaling decreasing performance

Haoxi Health Technology Limited's short-term assets of $19.60M exceed its short-term liabilities of $3.89M

Haoxi Health Technology Limited's return on assets of -13.42% is lower than the 5.00% threshold, indicating inefficient asset utilization

Haoxi Health Technology Limited's return on equity of -16.63%, is lower than 15.00%, indicating bad performance

Haoxi Health Technology Limited's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Haoxi Health Technology Limited has insufficient public price history to evaluate earnings stability.

Haoxi Health Technology Limited has negative free cash flow, indicating the company is burning cash rather than generating it

Haoxi Health Technology Limited has negative free cash flow, indicating cash burn

Haoxi Health Technology Limited's yearly earnings has increased 200.13% since last year from $1.29M to $3.88M, signaling increasing performance

Haoxi Health Technology Limited's yearly revenue has decreased 32.39% since last year from $48.52M to $32.80M, signaling decreasing performance

ROIC -43.02% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Haoxi Health Technology Limited's 3-year revenue CAGR of 26.63% is positive, indicating growing revenue over the past 3 years

Haoxi Health Technology Limited has insufficient public price history to evaluate revenue consistency.

Haoxi Health Technology Limited has insufficient public price history to evaluate ROE consistency.

Haoxi Health Technology Limited has insufficient data to evaluate this check.

Haoxi Health Technology Limited has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Haoxi Health Technology Limited is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Haoxi Health Technology Limited has insufficient data to compute enterprise value.

Haoxi Health Technology Limited has insufficient data to evaluate this check.

Haoxi Health Technology Limited has insufficient diluted EPS history to calculate the PEG ratio.

Haoxi Health Technology Limited has a price-to-book ratio of 0.04x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Haoxi Health Technology Limited has a price-to-sales ratio of 0.02x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue